Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A recent study of veterans found that antiretroviral treatment was not associated with a mitigated dementia risk.
A lawsuit alleges he tested HIV positive in 1995, but federal health care workers missed numerous chances to inform him.
In 2019, almost 172 million prescription drugs were sent by mail. Since COVID-19, that number has increased nearly 21%.
The Veterans Health Administration is the nation’s largest single provider of medical care to people with HIV.
An analysis of veterans seeking PrEP found that they often had to be extraordinarily persistent in their efforts to receive a prescription.
These risks include hospitalization and death.
Elsewhere in the Fiscal Year 2019 appropriations process, Congress attempts to restore order.
According to a recent study, such a disparity persists even when access to care for the virus is equal.
Known as polypharmacy, taking numerous medications has been linked to such risks in the general population as well.
Merck’s hepatitis C treatment cured almost all those with stages 3 through 5 of chronic kidney disease in a VA database.
This finding falls in line with numerous analyses that show that PrEP’s benefits are largely not reaching Black gay and bi men.
Real-world data showed Merck’s hep C regimen performed well among a population with genotypes 1 or 4 and multiple other health conditions.
The prevalence of each virus is up to three times higher among homeless versus non-homeless veterans.
A look at Proposition 61—the Drug Price Relief Act—before it goes to California voters in November.
The real-world cure rates offered by Sovaldi (sofosbuvir)-based hep C virus regimens have not been as good as those seen in clinical trials
Carl Huddleston, who claims he contracted hepatitis B from a Veterans Affairs (VA) hospital in Tennessee, missed the deadline to file a medica...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.